Elahere
Australian Public Assessment Report
Device/Product Name
Elahere
Active ingredients
Mirvetuximab soravtansine
AusPAR Date
Published
Sponsor
Submission Number
PM-2024-05687-1-4
Submission Type
New biological entity
Decision
Approved